Amplity · 1 day ago
Compliance Intern
Amplity is a full-service partner for biopharma companies, providing specialized medical and commercial services. The Compliance Intern will assist in various compliance-related projects, conduct research on industry regulations, and support internal audits while gaining valuable experience in the compliance field.
BiotechnologyPharmaceuticalService IndustrySmall and Medium Businesses
Responsibilities
Accepts designated, business-focused projects to research, propose ideas and solutions, and present a final project during the internship
Assist in document management and ensure policies are properly archived and accessible
Assist in researching and analyzing industry regulations, guidelines, and best practices (e.g., FDA, EMA, HIPAA, AKS, FCA, PhRMA, etc.)
Monitor changes in regulatory requirements and communicate potential impacts
Make notes and memos during meetings; type documents, drafts, and reports; sort and manage files
Support internal compliance audits by collecting, analyzing, and organizing data
Support the preparation of regular compliance reports and presentations for management
Analyze compliance-related data to identify trends, risks, or areas of concern
Track participation and delivery of compliance training
Qualification
Required
High school degree or equivalent; must be enrolled in an accredited university/college program
Professional, confident manner and poised and articulate demeanor
General knowledge of the MS Office suite, which includes MS Projects, PowerPoint, and Excel
Strong human relations skills and be able to work effectively with individuals of diverse backgrounds
Excellent follow-up and organizational skills
Judgment/decision-making capability and ability to remain composed
Ability to manage multiple priorities
Highly detail-oriented
Strong written and oral communication skills
Strong commitment to confidentiality and handling sensitive information
Company
Amplity
Amplity is a pureplay pharmaceutical commercialization service organization.
Funding
Current Stage
Late StageTotal Funding
$102.5M2022-01-18Debt Financing· $102.5M
2022-01-04Acquired
Recent News
2025-07-10
EIN Presswire
2025-05-28
Company data provided by crunchbase